Fellowship

The Australian Academy of Health and Medical Sciences elects the best and brightest minds in the field of medical and health sciences as Fellows.

Fellows are elected in recognition of their outstanding achievements and exceptional contributions to the sector. The Fellowship are acknowledged for their clinical, non-clinical, leadership, industry and research contributions.

About Fellowship with AAHMS

Find Fellows of the AAHMS

To find Fellows of our Academy either use the search form below or download the full list of current Fellows here.

Search
Generic filters
Search
Generic filters

Name

Position

Level

Elected

State

Former Director, Hopwood Centre for Neurobiology; SAHMRI Board member; Affiliate of the Nutrition and Metabolism Theme
South Australian Health and Medical Research Institute
Fellow
2015
SA

Professor John Hopwood established and has led the Lysosomal Diseases Research Unit since 1978. The Unit has been continually successful in basic and applied research into lysosomal disorders (LSD), and has made significant contributions to diagnostics and population screening methods for detection of LSD, and developing and applying novel treatments to humans. His leadership has effectively harnessed the capacities of others to achieve success in complex and interactive projects over the long-term that have led to successful commercialisation of two FDA-approved treatments, which are now treating thousands of patients world-wide, and to royalty returns of >$300m invested back into SA health and medical research projects. Hopwood was a key contributor to the foundation of South Australian Health and Medical Research Institute.

 

Director, Department of Gastroenterology & Hepatology
Princess Alexandra Hospital, QLD Health
Fellow
2015
QLD

During the last 30 years, Professor Holtmann has been very fortunate to be able to drive a paradigm shift for the pathophysiologic concepts of functional gastrointestinal disorders. While initially considered a ‘psychosomatic disorder’, his work identified genetic risk factors (e.g. the GNB3 polymorphism) and established a now widely accepted concept of minimal systemic inflammation as a driver for the manifestation of these conditions. Based upon these findings novel treatments can be developed that will allow to better treat and ultimately cure patients with these highly prevalent diseases.

Professor of Medicine
St Vincent Hospital Melbourne
Fellow
2015
VIC

Professor Hicks has made major contributions to the care of patients with cancer through his pioneering work with positron emission tomography (PET), which has now become a routine imaging test for selecting and monitoring cancer therapies. By applying this technology in translational research he has helped develop new cancer therapies, especially targeted drugs for malignancies previously without effective treatments. He is also an international leader in the field of neuroendocrine tumours, in which he has pioneered new forms of internal radiation delivery in combination with chemotherapy. He sits on multiple editorial and scientific boards and is Editor-in-Chief of Cancer Imaging. 

Scientia Professor; Executive Director, Centre for Primary Health Care and Equity
UNSW Sydney
Fellow
2015
NSW

Professor Harris is highly regarded for his research into the prevention and management of chronic disease in general practice and community health services, vulnerable population (including Aboriginal and refugee health) and access to primary health care. This has given rise to over 300 publications in the national and international peer review research literature and is highly cited. He leads and participates in international collaborative research with researchers in the US, Canada and the UK. His research has been highly influential with his profession including the development of clinical management guidelines and helped inform policy of the Commonwealth and NSW Governments.

 

Director
ANZAC Research Institute University of Sydney
Fellow
2015
NSW

David Handelsman is a world-leading authority on androgen physiology, pharmacology and toxicology arising from his sustained and wide-ranging clinical, experimental and public health research and discoveries in elucidating androgen action, use and misuse. He became Australia’s first Professor of Andrology (1996), created Australia’s first hospital Andrology Department (1999) and is inaugural Director, ANZAC Research Institute (1999). The most highly cited author and author of the major textbook chapters in his field, he has >450 papers, cited >16,000 times (h index 71) including an editorial for New England Journal of Medicine (2013) with his work highlighted by a Time magazine cover story on testosterone (2014).

Head, HIV Epidemiology and Prevention Program
Kirby Institute, The University of New South Wales
Fellow
2015
NSW

Professor Andrew Grulich is an internationally renowned authority in Immune deficiency, infection and cancer and Transmission and prevention of HIV. His work has documented how immune function influences cancer risk, and demonstrated effective HIV prevention in homosexual men. His finding that infection-related cancers occur at increased risk in transplant recipients overturned thinking about the role of the immune system in cancer prevention, and led to international clinical guidelines. His outstanding profile is evidenced by senior executive roles in international professional and scientific organisations, and a Thomson-Reuters citation record in the top 1% of his field.

Head, Gene Regulation Section
Centre for Cancer Biology
Fellow
2015
SA

Prof Goodall is a world leader in the biology of RNA and cancer progression. He has combined innovation with thoroughness to make discoveries that open new areas in RNA biology for development and exploitation. He has made seminal contributions to the understanding of mechanisms governing gene activity in cancer, through control of mRNA activity, regulation of gene expression by microRNAs, and most recently discovery of regulation of circular RNAs. These discoveries have widespread implications for understanding gene regulation in general, and in particular in immunity and cancer. His publications have received over 5000 citations in the past 5 years alone.

 

Professor of Human Genetics
The University of Adelaide
Fellow
2015
SA

Citation

Professor Gecz is leading international expert in genetics of paediatric neurological disorders, intellectual disability, epilepsy, autism and cerebral palsy. This is documented by his 277 scientific publications accumulating in excess of 15000 citations. Professor Gecz discovered >200 human disease genes and works tirelessly to translate this new knowledge into better health for the affected individuals and their families. He is NHMRC Senior Principal Research fellow and Chair for the Prevention of Childhood Disability at the University of Adelaide. Professor Gecz is a Founding Fellow of the Faculty of Science of the Royal College of Pathologists of Australasia and Fellow of the Australian Academy of Science.

Scientia Professor
The University of New South Wales
Fellow
2015
NSW

Scientia Professor Katharina Gaus is an acknowledged authority in the fields of cellular immunology and molecular microscopy. Her work has not only completely overturned our understanding of T cell activation, but we can now image and map signalling molecules in T cell synapses with nanometre precision. Her frequently world-first research achievements are matched by her profile both nationally and internationally, with many esteem measures to her name including receipt of the prestigious Gottschalk Medal of the Australian Academy of Science.

Vale Katharina Gaus, March 2021

Laureate Professor; Director, Priority Research Centre for Healthy Lungs; Director, Vaccines, Immunology, Viruses and Asthma Program
University of Newcastle
Fellow
2015
NSW

Laureate Professor Paul Foster, DSc (ANU), undertakes research which has transformed the way scientists understand the fundamental molecular and cellular processes that regulate allergic inflammation, and how they contribute to the pathogenesis of asthma and eosinophilic disorders.  These include seminal findings on how cytokines (interleukins (IL)) derived from T-helper cells contribute to allergic disease.  Notably, these observations provide the platform for the pharmaceutical industry to develop new therapies for the treatment of asthma and eosinophilic disorders.  This is exemplified by successful clinical trials where inhibition of IL-5 and IL-13 has improved the health of patients with severe asthma. Professor Foster continues to play a critical role in shaping new clinical approaches to the management of patients with asthma and other airway diseases.

Our Fellows sit at the heart of everything we do. They represent Australia’s leading minds in health and medical sciences, having been recognised for their clinical, non-clinical, leadership, industry and research contributions.

To be considered for election to the Academy’s Fellowship, a candidate must show exceptional professional achievement in a field related to health and/or medicine.

Fellows contribute to the projects and activities of the Academy and must be willing to be active participants.

Successful Fellowship candidates will have shown:

  • Outstanding leadership in their field.
  • Significant and ongoing involvement with issues of health care, prevention of disease, education, research, and health services policy and delivery.

Candidates for Fellowship should meet the following criteria:

  • National and International recognition for excellence in health and medical science
  • Significant, sustained and ongoing contributions to advance health and medical science in Australia (relative to opportunity)
  • Contribution to the profession through leadership and mentorship
  • Raised public understanding and promoting health and medical science in the broader community



Download criteria for Fellowship

Each year, current Fellows of the Academy are invited to nominate up to four new candidates who meet the criteria and fulfil the required expectations.

Nominations by a Fellow of two new candidates must ensure that at least one nomination is a woman. Nominations by a Fellow of four new candidates must ensure that at least two nominations are women.

How to make a nomination

Fellows wishing to nominate a candidate for Fellowship should contact the secretariat to confirm candidate eligibility and receive and instructions on how to submit the completed nomination documentation online. 

Fellows wishing to nominate a candidate for a Corresponding Fellowship should contact the secretariat for more information.

Secretariat contact details
Email: [email protected]

Phone: 07 3102 7220

Nomination guidelines for ordinary Fellowship

October 2022
Newly elected Fellows of 2022 are inducted at the Annual Meeting.

Late September 2022-November 2022
Nominations are invited from existing Fellows until the closing date of 30 November.

December 2022
Nominations allocated to Selection Committees.

January – April 2023
Referees’ reports sought.

Early May 2023
Selection Committees meet to consider nominations and provide final recommendations to the Council.

Early-to-mid-July 2023
Council meets to finalise recommendations.

Late July 2023
Full Fellowship invited to comment on recommended new fellows.

August 2023
Election results are shared with proposers and candidates (under embargo).

October 2023
Newly elected Fellows of 2023 inducted at the Annual Meeting.

Keep up to date with the latest news

By providing your email address, you consent to it being added to our mailing list.